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Population requirement for primary knee
replacement surgery: a cross-sectional study
P. Ju¨ni1,2, P. Dieppe2, J. Donovan2, T. Peters3, J. Eachus2,
N. Pearson2, R. Greenwood2 and S. Frankel2
Objectives. To determine the population requirement for total knee replacement
(TKR) in England
Methods. Population-based study using an ageusex-stratified random sample of
28 080 individuals aged 35 yr and over. Incident disease was estimated from
prevalence by statistical modelling. The New Zealand priority criteria for major
joint replacement were used for case selection.
Results. Patients with knee disease were less likely than those with equally severe
hip disease to have been referred to a specialist, to have consulted an orthopaedic
surgeon or to be on a waiting list for joint replacement. The estimated annual
requirement of TKRs in England, based on New Zealand Scores alone, was 55 800
(95% CI 40 700–70 900), contrasting sharply with an annual provision of 29 300
actually observed. However, in contrast to previously reported hip replacement
data, when patient willingness to undergo surgery was considered, this estimate
decreased considerably.
Conclusions. There appears to be an underprovision of TKR in England. This
may be due in part to differences in perception of disease severity and likely
response to surgery between patients and general practitioners on one hand, and
rheumatologists and orthopaedic surgeons on the other.
KEY WORDS: Knee replacement surgery, Needs assessment, Population requirements.
Total knee replacement (TKR) is an effective interven-
tion for patients with severe knee disease. Systematic
reviews have shown that all forms of primary knee joint
replacement result in large improvements in patient-
related outcome measures for the majority of those
undergoing these procedures w1, 2x. Although the number
of TKRs performed in England has been rising each year
over the last two decades w3x, one population-based study
w4x and some commentators w5x have suggested that there
is still a large unmet need for primary TKR in England.
However, the current evidence base is limited. Some
prevalence data on severe knee disease in the community
are available w4x, but incidence data to estimate the
annual population requirement for knee replacement are
lacking. Consensus criteria for case selection for TKR
have been published w6, 7x, but data on the impact of
these criteria on annual rates are unavailable, and the
implications of different thresholds for surgery, patient
preference and other modifiers of the decision to
recommend surgery are unclear.
In a previous paper w8x we used prevalence data of hip
disease from the Somerset and Avon Survey of Health
(SASH) w9x to estimate the annual population require-
ment for primary hip replacement in England. To inform
the current discussion, we used the same methods and
assumptions to estimate the population requirement for
primary TKR. In addition, we compared healthcare
utilization by people with hip and knee disease.
Patients and methods
Sampling of patients
SASH is a population-based cross-sectional study described
elsewhere w8, 9x. We used a multistage sampling strategy w10x.
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Forty practices were selected from Avon and Somerset. From
each practice, 702 people aged 35 yr and over were randomly
selected using ageusex stratification, resulting in a sample of
28 080 people with the numbers of men and women in each
10-yr age band reflecting the population distribution of Avon
and Somerset w9x. After exclusion of 2034 people who had
moved out of the study area, suffered from a severe mental ill-
ness or a terminal illness, or were deceased, 26 046 people were
included in the study. Approval was obtained from the relevant
Local Research Ethics Committees (Southmead, Frenchay,
United Bristol Health Trust, Weston and Somerset) w8x.
Screening process
All 26 046 people were sent a screening questionnaire com-
prising questions on general health, utilization of health services
and symptoms of hip and knee disease. Non-respondents were
sent two reminders and contacted by phone, if necessary w9x.
We screened people for knee pain using a modified version of
the question used in the first National Health and Nutrition
Examination Survey w11x: ‘During the past 12 months, have
you had pain in or around either of your knees on most days
for 1 month or longer?’ Participants who reported knee pain
were invited for further examination either at a clinic or by
home visit. Examinations were organized in two phases by
location of participating practices (Fig. 1). During phase 1, the
first 1249 participants who reported knee pain were invited for
examination. During phase 2, 2062 participants were invited.
In this phase, 904 participants under the age of 65 yr were
excluded from invitation because their walking capacity was
not severely limited (self-reported walking time an hour or
more) or was limited due to self-reported conditions unrelated
to joint disease; these individuals were excluded from the
extrapolations described below.
Orthopaedic assessment
Interviewer-administered questionnaires were completed on
knee pain and stiffness, activities of daily living, use of health
services and referral to specialist care. Participants were asked
whether they had received drug therapy for their knee pain in
the previous year, whether they suffered from symptoms that
might make them unfit for surgery (chest tightness, wheeze,
breathlessness, chest pain or palpitations) and whether they
would accept surgery if it were offered, with a follow-up
question to elicit the reasons for their view. A clinical
examination of hip, knee and lower back was carried out by
a physician and a team of nurses with orthopaedic experience
who had undergone a standard training programme.
Criteria for case selection
As in the previous report on hip replacements w8x, the New
Zealand priority criteria for major joint replacement surgery w7x
(New Zealand Score) were used for case selection for primary
TKR. In a pilot study, agreement of the developed criteria with
overall clinical judgement was found to be excellent w12x. The
final composite score included subscores on pain (40 points),
disability (20 points), clinical findings (20 points), multiple joint
disease and ability to live independently (20 points), and ranged
from 0 to 100 with higher scores reflecting more severe disease.
No agreed cut-off point for case selection had been proposed
originally. To reflect severe and moderate disease, however, we
chose a priori threshold scores of 55 (primary cut-off) and 43
(secondary cut-off), respectively, as were used in the previous
report on hip replacement w8x. Examples for degrees of pain
and disability associated with these cut-off points have been
published previously w8x.
Statistical methods
Incidence and prevalence calculations were identical to those
published for hip disease w8x. We calculated age- and sex-specific
prevalence of already replaced knees for those responding to
the screening questionnaire. Then we estimated the prevalence
of knee disease warranting total joint replacement (cut-off
points 43 and 55 on the New Zealand Score) using extrapola-
tions from the examined group of participants to the overall
group reporting symptoms with ageusex-specific sampling
fractions and the assumption that attendees and non-attendees
were similar. New Zealand Scores were not assigned to knees
that had already been replaced (Fig. 1).
Examiners found it difficult to complete the examination in
people with severe knee disease, resulting in incomplete clinical
data wodds ratio (OR) for missing clinical information per 10-
point increase of New Zealand disability subscore 2.85, 95%
confidence interval (CI) 2.14–3.81x. Excluding participants with
incomplete data would have led to an underestimation of the
population requirement for knee replacement. We therefore
imputed scores for 193 right and 198 left knees with incomplete
data (Fig. 1), using a multivariable linear regression model
with the subscales on pain, disability, multiple joint disease and
ability to live independently as predictor variables. Based on
data from 1859 participants with complete information, we
found excellent agreement between predicted and original scores
(intraclass correlation coefficient 0.988, 95% CI 0.987–0.989).
Incidence was calculated by the method of Leske et al.
w13x, using the increase in prevalence between consecutive age
bands to calculate age-specific incidence. Its assumptions haveFIG. 1. Study flow diagram.
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been discussed before w8x. We considered prevalence data for
replaced and severely diseased knees (New Zealand Scores
0 43 or 55 points) separately and smoothed both by fitting
quadratic models across age-groups in logistic regression
analysis. Then we included ageusex-specific death rates. The
annual number of TKRs needed in the population of England
was calculated by multiplying point estimates and 95% CIs of
ageusex-specific incidences by population figures for England.
This number was modified by excluding those assumed to be
unfit for surgery (self-reported chest tightness, wheeze, breath-
lessness, chest pain or palpitations many times a day or all the
time), those who had not had a trial of medical therapy in
the past year and those who indicated they might not accept
surgery if offered. Since individuals were sampled within
practices, we examined the effects of clustering on the standard
error of the age- and sex-specific prevalence of self-reported
knee pain w8x.
For exploratory analyses, we defined index joints as the
symptomatic hip or knee with the highest New Zealand Score
(1302 index hips and 2056 index knees). We used logistic
regression models to compare the use of health services and
referral to specialist care for knee disease with that hip disease,
using robust standard errors, which allowed for correlation
within participants who suffered from both knee and hip
disease, and adjusting for disease severity. In a further analysis
we also adjusted for age, gender, and willingness and fitness
for surgery; because of missing data this analysis was based on
2928 index joints only. Finally, we extracted the annual number
of primary TKRs performed in English NHS hospitals from
first episodes of 1997 Hospital Episode Statistics (codes W40.1,
W41.1 and W42.1) w3x. The number of procedures performed
independently was estimated using data from a 1997 national
survey of private hospitals in England w14x.
Results
Figure 1 shows the flow of participants through the
study. A total of 22 978 responded to the screening
questionnaire, and 22 379 completed the question on
knee pain; 4799 reported knee pain on most days for
1 month or longer in the past year (21.4%, 95% CI 20.9–
22.0). Prevalence of knee pain increased with age, from
12.4% in those aged 35 to 44 yr (95% CI 11.6–13.3), to
37.8% in those aged 85 yr and above (95% CI 33.5–42.1),
and was higher in women (23.6%, 95% CI 22.9–24.4)
than in men (18.9%, 95% CI 18.1–19.6). The cluster
design had negligible effects on the width of 95% CIs of
ageusex-specific prevalences, with a median design factor
of 1.12.
A total of 3311 participants with knee pain were
invited for further examination (69.0%), and 2117
attended (63.9%). As reported for hip disease w8x,
attendees were more likely than non-attendees to have
sought care for knee disease (data available on request);
however, the differences were smaller than for hip
disease. Attendance rates ranged from 46.0% in women
aged 35–44 yr to 79.9% in men aged 65–74 yr.
Table 1 presents ageusex-specific estimates of the pre-
valence of TKR and severe knee disease. The prevalence
of primary TKRs was 8.4 joints per 1000 people aged
35 yr and over (95% CI 7.2–9.5), considerably lower than
that of total hip replacements. Using the primary cut-off
of 55 points on the New Zealand Score, we found an
estimated population prevalence of knee disease requiring
total joint replacement of 27.4 joints per 1000 people
aged 35 yr and over (95% CI 24.7–30.1), increasing to
64.3 with a cut-off of 43 points (95% CI 60.8–67.7).
Prevalence figures translated into an estimated inci-
dence of 55 800 knees for a cut-off of 55 points (95% CI
40 700–70 900) and 101 500 knees for a cut-off of 43
points (95% CI 80 200–122 700), respectively, requiring
TKR annually in England, contrasting sharply with the
annual number of primary TKRs actually performed in
1997: 24 200 in the NHS w3x and an additional estimated
5100 in independent hospitals w14x. Figure 2 shows the
effect on estimates when suitability for surgery and
patients’ preferences were accounted for, comparing
results with those previously published for hips w8x. The
number of people requiring TKRs decreased to about
half of the initial estimate after exclusion of those who
were unfit for surgery, had not had a trial of medical
therapy and who had indicated they did not want a
surgical intervention (29 100, 95% CI 16 300–41 900).
Willingness to consider surgery had a particular impact
on incidence estimates. About one-third of participants
considered for TKR indicated that they would not
accept surgery if offered, irrespective of the cut-off point
used. Table 2 documents some of the reasons for their
view. The majority of participants was concerned about
the risks and benefits of TKR. In multivariable logistic
regression analysis, willingness to undergo surgery was
more frequent in severe disease (OR per 10-point
increase of the New Zealand Score, 1.57, 95% CI 1.47–
1.66), but less frequent in the elderly (OR per 10-yr
increase in age, 0.71, 95% CI 0.65–0.77) and in women
(OR 0.60, 95% CI 0.49–0.74).
Data on health services utilization and referral to
specialist care, comparing knee with hip disease, is
summarized in Fig. 3. After adjustment for severity of
disease those with knee disease were more likely than
those with hip disease to have sought care from their GP,
but less likely to have been referred to specialist care, to
have consulted an orthopaedic surgeon or to be on a
waiting list for joint replacement. Differences remained
TABLE 1. Crude ageusex-specific prevalence of primary total knee
replacement and severe knee disease (New Zealand Scores0 55 points)
Gender
Age band
(yr)
Rate per 1000 (95% CI)
Total knee replacement Severe knee disease
Female 35–44 0.3 (0.0–1.0) 3.6 (0.2–7.0)
45–54 2.6 (0.7–4.5) 9.4 (4.0–14.8)
55–64 6.5 (3.3–9.7) 25.0 (17.0–33.1)
65–74 15.0 (10.1–19.9) 60.1 (48.0–72.1)
75–84 38.8 (29.0–48.7) 123.4 (101.5–145.3)
085 41.9 (21.7–62.0) 122.0 (74.4–169.6)
Total 10.7 (8.9–12.5) 37.3 (33.0–41.5)
Male 35–44 0.7 (0.0–1.8) 2.7 (0.0–5.7)
45–54 1.6 (0.0–3.3) 14.4 (8.4–20.4)
55–64 7.2 (3.7–10.7) 20.3 (12.9–27.8)
65–74 8.5 (4.4–12.7) 21.9 (14.0–29.8)
75–84 17.7 (9.1–26.4) 35.3 (19.8–50.8)
085 20.3 (0.0–43.2) 30.6 (0.0–70.9)
Total 5.5 (4.1–7.0) 15.6 (12.7–18.6)
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after additional adjustment for age, gender, willingness
and fitness for surgery (Fig. 3), and after restriction to
severe disease only (data available on request).
Discussion
Knee disease is very common in adults. In agreement
with other UK-based studies w15x, we found an overall
prevalence of chronic knee pain of 21.4% in those aged
35 yr and over. However, the majority of people with
knee pain do not suffer from severe disease. A variety of
outcome instruments are available to help grade the
severity of symptoms, such as Lequesne’s index w16x or
WOMAC w17x, but these instruments were not developed
for case selection for TKR. In contrast, the priority
criteria from Ontario, Canada w6x and New Zealand w7x
were produced for this very reason.
The New Zealand Criteria w7x provide a numerical
score which can be used to define indications for surgery
from population-based data w9x. The question which
then arises is what threshold of severity should be used
to indicate likely need for joint surgery? The prevalence
of participants with a New Zealand Score of 43 or
more, which indicates a significant degree of pain and dis-
ability, was 4.2%, about one-fifth of the 21.4% reporting
knee pain. When we increased the threshold to 55, which
indicates severe disease of a sort that we consider severe
enough to warrant surgery, the prevalence fell further,
to 1.9%. Interventions such as TKR are provided on
an incident basis, so we converted prevalence figures
to incidence data. Using the higher cut-off point this
translated to a calculated annual need for 55 800 TKRs,
about twice the rate currently provided in England.
Rates vary greatly in different countries w18x, and our
TABLE 2. Reasons for reluctance to undergo knee replacement surgery
for participants with New Zealand Scores 0 55 points
n (%)
Considered for total knee replacement 181
Unwilling to consider surgery 58 (32.0)
Information on reasons available 56
Concern about risks and benefits of surgery 26 (46.4)
Symptoms perceived as not severe enough 19 (33.9)
Too old 18 (32.1)
Comorbid conditions 12 (21.4)
Other reasons 7 (12.5)
The first 40 participants of phase 1 considered for TKR were
excluded because they were not asked about reasons for refusing
surgery. The sum of percentages does not add to 100% because more
than one reason could be indicated.
FIG. 2. Estimated annual number of incident knee and hip disease requiring primary total joint replacement surgery for those aged
35–85 yr in England. Expressed as 1000s of joints.
FIG. 3. Presented are ORs of use of health services and referral for knee compared with hip disease adjusted for disease severity
(initial adjustment), and disease severity, age, gender, willingness and fitness for surgery (full adjustment). The questions asked
related to the use of health services or referral specifically for the diseased index joint (2056 knees vs 1302 hips). An OR >1
indicates that health services are more frequently used for knee disease, an OR <1 indicates the opposite.
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estimate of the likely population need accords well with
the rates found in the USA w19x, where adequate
provision is assumed: 92 per 100 000 of the overall
population, corresponding to about 58 000 operations
performed annually in England.
When estimates were adjusted for potential modifiers
of the decision to recommend surgery (fitness, willingness
and previous drug therapy), the incidence estimates
decreased to nearly one-half of the initial figures.
Reluctance to undergo surgery appeared to have a par-
ticular impact. The most frequent reason for reluctance
were concerns about the risks and benefits of TKR and
the perception that symptoms were not severe enough to
warrant surgery. Interestingly, women and older people
were particularly unwilling to undergo knee surgery.
Gender differences in attitudes towards surgery w20x and
lay views that even severe knee disease is an expected
accompaniment of ageing w18xmay be responsible for this.
Although patient preference may play an important
role, barriers at the level of care providers may also be
involved. We found interesting differences between hip
and knee disease in the pattern of health services
utilization along the whole pathway to joint replacement
w18x, with a lower provision of care for knee disease.
Referral patterns by primary care physicians may be of
particular importance. Differences remained, however,
when we adjusted for referral to specialist care (data
available on request), indicating that differential provi-
sion of care may also be an issue at the level of spe-
cialists. Part of this difference may be due to the fact that
hip disease often deteriorates rapidly, with a relatively
sudden increase in the level of pain w21x, while knee
disease may follow a course of slower deterioration,
giving patients and doctors more time to adjust to and
accept increasing severity w22x.
TKR was initially considered a poor intervention w5x.
Many of the early designs failed, with hinged prosthesis
designs causing particular problems. Current unre-
strained designs are considered very successful, however
w5x. Observational evidence suggests that these designs
now result in long-term symptomatic benefit and survival
rates that are comparable with those of contemporary
hip replacements w23–27x. Negative perceptions among
patients, and the differential rates of referral observed
for knee and hip disease, which suggest negative
attitudes among physicians as well, may be the now
inappropriate legacy of the early failings of TKR.However,
other recent data from our group suggest that patient
outcomes may not always be as good as we might expect
w28x, so these findings indicate that TKR may be an
intervention for which the views of rheumatologists,
surgeons and evidence-based medicine sometimes conflict
with those of the patients and their general practitioner.
The limitations of our approach to estimate popula-
tion requirements for joint replacement have been
discussed previously w8x. However, several limitations
deserve further attention. First, there is no satisfactory
evidence base to define criteria for case selection for
TKR w18x. The consensus criteria w7x we chose are
standardized and validated w12x; however, and the cut-off
points applied as possible thresholds for surgery (43 and
55 points on the New Zealand Score) correspond well
to the severity of disease observed in the majority of
patients assessed prior to total joint replacement in
England w29, 30x. In one study recently performed on 203
randomly drawn patients from a waiting list for hip and
knee replacement, about 60% had New Zealand Scores
>55, and approximately 80% >43 w30x. In addition,
radiographic findings may play a role in the decision to
recommend surgery w31x, but we have not incorporated
radiographic findings into these criteria in view of the
low attendance rate for radiographic examinations, low
correlation between radiographic findings and clinical
disease severity, and uncertainty as to how best to
integrate radiographic information into the score.
Secondly, severe knee disease may be associated with
comorbid conditions (such as severe obesity) w32x, which
may in turn increase mortality risk w33x. This would lead
to an underestimation of the actual incidence of severe
disease, though not affect the incidence estimates for the
requirement for knee replacement. Thirdly, we had to
include already replaced joints in our calculations in
addition to those considered towarrant total joint replace-
ment. Differences in current operation rates for hip and
knee disease will therefore influence our incidence esti-
mates. Because of the smaller prevalence pool of TKRs
as compared with total hip replacements, our estimates
tend to be more conservative than those previously
published for hips w8x. Fourthly, we attempted to adjust
incidence estimates for potential modifiers of the deci-
sion to recommend surgery. These modifiers were assessed
by means of a standardized interview rather than through
conversations with patients and orthopaedic surgeons.
This does not reflect true clinical decision-making and
may bias our adjustments. However, our approach was
standardized and identical for hip and knee disease, and
identified important differences.
In conclusion, we suggest that there is considerable
underprovision of TKR in England. Our study indicates
that this may not simply be due to a failure of the
National Health Service to satisfy demand, but also
because of reluctance by patients and doctors to consider
surgery, even for severe knee disease. This suggests an
urgent need for a review of policies for the management
of knee disease in England.
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